InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.20
(
0.91%
)
US TECH 100
17,077.60
(
1.29%
)
Dow Jones
38,225.66
(
0.85%
)
Brent Oil
83.63
(
0.10%
)
Bitcoin
59,007.75
(
1.32%
)
Post# of 7239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

iwfal

Send PM Follow Ignore
Followers 75
Posts 4648
Boards Moderated 0
Alias Born 09/06/2003

iwfal

Member Level

Re: DewDiligence post# 6400

Monday, 03/04/2024 11:29:29 AM

Monday, March 04, 2024 11:29:29 AM

Post# of 7239

RVNC is not going to spend money on a migraine trial anytime soon (if ever).



Per Revance’s charts (I’ve not tried to verify it) migraine is the biggest therapeutic indication. By far (per charts: CD is 14%, ULS is 27%, Migraine is 40%). It makes sense for them to spend money to make it easy for injectors to switch to it - especially after their experience with the esthetic injectors being unwilling or incapable of developing their own protocols.

Whether this means full approval, or just running a really clean ph2, or sponsoring several Independent Investigator trials … I don’t know. But it’s almost certainly very worthwhile for them to spend $ ASAP to get access to this market.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RVNC News
More RVNC News
InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!